Nppa

NPPA allows drug firms to raise prices of essential medicines from April 1

Effectively the prices of 651 medicines will come down by 6.73%; WPI-linked price rise allowed this fiscal is 12.2%; about 870 formulations fall under the essential category

Sanitary napkins, diapers likely to be included in essential drugs list

Sub-committees were formed earlier to categorise medicines, medical devices, disposables, and other health and hygiene products according to how essential they are for healthcare

Drug pricing regulator NPPA revises ceiling prices of 128 medicines

As per the notification, the ceiling price of one Amoxicillin capsule has been fixed at Rs 2.18; one tablet of Cetirizine at Rs 1.68

Coronary stents may become more affordable, NPPA to decide price

The Union health ministry has notified the inclusion of coronary stents in the National List of Essential Medicines, 2022, a move that will help make these life-saving medical devices more affordable. The move is based on the recommendations by an expert committee constituted to review the inclusion of stents in the list based on requirement. The National Pharmaceutical Pricing Authority (NPPA) will now fix the price of coronary stents. On November 6, the Standing National Committee on Medicines (SNCM) had submitted its recommendation for inclusion of coronary stents in the National List of Essential Medicines (NLEM), 2022 in two categories -- Bare Metal Stents (BMS) and Drug Eluting Stents (DES) which include metallic DES and bioresorbable vascular scaffold (VBS)/biodegradable stents. According to minutes of the SNCM meeting, vice chairman Dr Y K Gupta stated that coronary stents were earlier included in NLEM, 2015 through a separate notification based on the recommendations of an

Essential medicines to get cheaper in India after the release of NLEM

The medicines listed in the NLEM are sold below a price ceiling fixed by the National Pharmaceutical Pricing Authority (NPPA)

Streamlining trade margins on drugs priced Rs 100 and above likely

Drugs for ailments like chronic kidney disease, some high end antibiotics, anti-virals (anti-infectives), as well as some cancer drugs are likely to be brought under trade margin rationalization first

WPI effect: 800 key drugs likely to see 10% price rise in April

While the NPPA may allow a 10 per cent rise in prices of NLEM drugs based on WPI this year, the actual price rise could be less, say drug firms

Covishield, Covaxin prices likely to be capped at Rs 275 per dose

Additional Rs 150 could be service charge; regular market nod expected soon

NPPA fixes price caps for 12 anti-diabetic medicines

These include glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet

NPPA has fixed ceiling prices of 355 medicines, 882 formulations: Mandaviya

The National Pharmaceutical Pricing Authority has fixed ceiling prices of 355 medicines and 882 formulations under the National List of Essential Medicines, 2015, Parliament was informed

Oximeters, BP machines to get cheaper as NPPA caps trade margins at 70%

Earlier margins were as high as 709% for some devices; revised prices will come into effect from July 20

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

These are scheduled drugs (or ones that are under price control) and low priced

NPPA ensured availability of essential drugs during pandemic: Eco Survey

Drug pricing regulator NPPA undertook necessary steps to ensure availability of life saving essential medicines across the country during the COVID-19 pandemic, the Economic Survey said on Friday. Drug prices in India are regulated to ensure continued availability and affordability of essential medicines with improved access to consumers, it added. "National Pharmaceutical Pricing Authority (NPPA)... has played an active role in addressing the exigencies arising out of COVID-19 pandemic and undertook necessary measures to ensure continued availability of life saving essential medicines throughout the country," the survey said. The regulator invoked extraordinary powers in public interest to ensure that policy enhances access to life saving drugs like Heparin as well as medical oxygen, it added. Timely intervention by NPPA eased the situation of medical oxygen availability throughout the country, especially in distant and far-flung areas. The survey said NPPA also ensured availabil

Price monitoring and resource unit set up in Goa under aegis of NPPA: Govt

A price monitoring and resource unit has been set up in Goa under the aegis of the National Pharmaceutical Pricing Authority (NPPA), the government said on Saturday

Covid-19: NPPA caps price of liquid medical oxygen, cylinders for 6 months

The present situation of Covid-19 has resulted in increased demand of medical oxygen up to almost four times from 750 MT per day to around 2,800 MT per day, the Ministry said

Regulator extends price cap on knee implants by one month till Sept 15

The NPPA had allowed firms to take a 10 per cent hike for their knee implant products last year

Drug price monitoring unit set up in Karnataka under aegis of NPPA

The government on Thursday said aprice monitoring and resource unit (PMRU) has been set up in Karnataka under the aegis of the National Pharmaceutical Pricing Authority (NPPA)

Top biz headlines: GoAir stops int'l ops, exporters seek govt aid, and more

From GoAir suspending international flights to digital payments getting the boost amidst Covid-19 concerns, Business standard brings to you the top headlines of the day

NPPA allows differential price for Meril's biodegradable cardiac stent

The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent

Cipla, Glenmark get NPPA nod for inhaler pricing over 'innovative' quotient

Glenmark had appealed to the pricing regulator in 2016 asking for a differential price for its Digihaler